Digital Channels and the Counterfeit Prescription Drug Market: From Supply Chain to Customer
Posted on December 17, 2013
By: Aaron Graham, Director of Brand Safety & Security
Boehringer Ingelheim Pharmaceuticals
Law enforcement officials, brand owners, technology specialists and scientists work together to fight the illegal trade. The scourge of counterfeit medicines becomes personal for all of us as we naturally become caregivers and patients in our lifetime. When my own mom was diagnosed with pancreatic...
To read the full article and other articles in this issue, please register for a free account or log in.
We will not sell or give your information to a third party. See our Privacy Policy
Related Topics and Keywords
API, Boehringer Ingelheim Pharmaceuticals, Cancer, Center for Medicine in the Public Interest (CMPI), counterfeit, FDA, Oncology, Supply Chain, U.S. Department of Justice, WHO
Related Products
Long-wavelength Dispersive 1064nm Handheld Raman - Rigaku Raman TechnologiesSubscribe to our FREE newsletter and WEBINAR UPDATES
We will not sell or give your information to a third party. See our Privacy Policy
